Spotlight -

Concierge Medicine Forum|

News|Videos|June 28, 2024

PAI: Introducing the Physicians Advocacy Institute

Author(s)Richard Payerchin

CEO discusses consolidation in health care.

In June 2024, the Physicians Advocacy Institute sent a letter outlining concerns about effects of consolidation in health care to three federal agencies reviewing current market conditions: The U.S. Departments of Justice, Health and Human Services, and the Federal Trade Commission. CEO Kelly Kenney, JD, introduces the Physicians Advocacy Institute with some history about the organization.

Newsletter

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Related Content

Off the Chart: A Business of Medicine Podcast - Ep. 181: Why physicians are getting sued less and paying more, with The Doctors Company President Robert White

Why physicians are getting sued less and paying more, with The Doctors Company President Robert White

ByAustin Littrell

August 31st 2026

Nearly 1 in 4 NFL players had CTE at death; first U.S. measles deaths of 2026 reported in Pennsylvania; Dolly Parton's health care legacy — Morning Medical Update Weekly Recap

Nearly 1 in 4 NFL players had CTE at death; first U.S. measles deaths of 2026 reported in Pennsylvania; Dolly Parton's health care legacy — Morning Medical Update Weekly Recap

ByAustin Littrell

August 28th 2026

Caroline Pearson: ©PHTI

Why fee-for-service could push AI's health care costs up, not down

August 28th 2026

Amazon Health AI’s digital front door may close the door on independent primary care

ByRobert Resnik, M.D., MBA

August 28th 2026

Expert Insights

11 practice models physicians are using to take back control of the business © Khunatorn - stock.adobe.com

11 practice models physicians are using to take back control of the business

ByAustin Littrell

August 27th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Medical Economics

When a device maker goes dark: What the Boston Scientific cyberattack means for your patients

Amazon Health AI’s digital front door may close the door on independent primary care

No Surprises Act payment dispute process booms to $22.4 billion cost in 4 years: study

Employer health care costs brace for a volatile 2027

11 practice models physicians are using to take back control of the business